Cumberland Pharmaceuticals Inc. - Common Stock (CPIX)
3.7100
-0.1700 (-4.38%)
NASDAQ · Last Trade: Jul 17th, 6:34 PM EDT
Via Benzinga · May 6, 2025
Via Benzinga · March 21, 2025

Keep an eye on the top gainers and losers in Wednesday's session, as they reflect the most notable price movements.
Via Chartmill · February 19, 2025

Cumberland just reported results for the first quarter of 2024.
Via InvestorPlace · May 7, 2024

Cumberland just reported results for the fourth quarter of 2023.
Via InvestorPlace · March 5, 2024

Curious about what's happening in today's session? Check out the latest stock movements and price changes.
Via Chartmill · February 5, 2025

Here are the top movers in Wednesday's session, showcasing the stocks with significant price changes.
Via Chartmill · February 5, 2025

The regular session of the US market on Tuesday is now over, but let's get a preview of the after-hours session and explore the top gainers and losers driving the post-market movements.
Via Chartmill · February 4, 2025

Curious about what's happening in today's session? Check out the latest stock movements and price changes.
Via Chartmill · February 4, 2025

Before the US market kicks off on Tuesday, let's examine the pre-market session and unveil the notable performers among the top gainers and losers.
Via Chartmill · February 4, 2025

Cumberland Pharmaceuticals' Phase 2 trial shows ifetroban improves heart function in Duchenne muscular dystrophy patients.
Via Benzinga · February 4, 2025

Via Benzinga · December 10, 2024

Via Benzinga · December 10, 2024

FDA approval streamlines Acetadote dosing, enhancing safety and efficiency in treating acetaminophen-related liver injury in hospitals worldwide.
Via Benzinga · December 10, 2024

Via Benzinga · December 10, 2024

Gainers
Via Benzinga · May 23, 2023

Companies Reporting Before The Bell • NIO (NYSE:NIO) is estimated to report quarterly loss at $0.51 per share on revenue of $2.29 billion.
Via Benzinga · March 5, 2024

Gainers Applied UV, Inc. (NASDAQ: AUVI) shares rose 44.6% to $0.69 in pre-market trading after posting better-than-expected quarterly sales.
Via Benzinga · May 23, 2023

The FDA has approved expanded labeling for Cumberland Pharmaceuticals Inc's (NASDAQ: CPIX) Caldolor, an intravenously delivered formulation of ibuprofen,
Via Benzinga · May 15, 2023